Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Image

Linerixibat accepted for priority review in China for cholestatic pruritus in patients with primary biliary cholangitis

Article Created on 26 Feb 2026 by GSK News Feed

Submission based on data from positive GLISTEN phase III trial

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement